Pemazyre
← BackMedicinal product
Pemazyre
Pemigatinibas
13,5 mg
tabletės
vartoti per burną
Receptinis
No
L01EN02, pemigatinib
Incyte Biosciences Distribution B.V., Nyderlandai
2021-03-26
Registruotas
No
8(3)
Centrinė registracija
Qualitative and quantitative composition
| Tablet | 1 vnt. |
|---|---|
| Pemigatinibas | 13,5 mg |
Packages
| PAKID | NPAKID | NPAKID-7 | Pack type | Pack size | Type of packaging | Proposed dispensing/classification | Marketing authorisation no. | Supply status | From | To | Package is in foreign language | From | To | Mock-up |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106216 | 92317 | 1092317 | lizdinė plokštelė | N14 | Receptinis | EU/1/21/1535/005 | Netiekiama | - | - | No | - | - | ||
| 106217 | 92318 | 1092318 | lizdinė plokštelė | N28 | Receptinis | EU/1/21/1535/006 | Netiekiama | - | - | No | - | - |
Stadijos
| Data | Stadija |
|---|---|
| 2021-03-26 | Registruotas |

